• info@dpml.cm

  • Call Us: +(237) 222-21-92-81

  • Time: Lundi-Vendredi: 07.30-15.30

Stopping exploitation of the marketing autorisation of Bivalent Oral Polio Vaccine Type 1 and 3, Oral suspension in multidose vial.

Vote utilisateur: 0 / 5

Etoiles inactivesEtoiles inactivesEtoiles inactivesEtoiles inactivesEtoiles inactives
 

The Minister of Public Health informs Public health professionals that SANOFI Laboratorieshave given up the exploitation of the marketing autorisation of their brand name product below :

Designation, dosage, form and presentation Marketing authorization number
Bivalent Oral Polio Vaccine Type 1 and 3, Oral suspension in multidose vial N°7771702

 

Stocks currently available in pharmacies can be sold and new importations will be subject to Special import exemptions./-

Yaoundé, May 06, 2020

Download the press release here (Pdf; 570Ko).

 

 {aridoc engine="pdfjs" width="100%" height="800"}/images/Alertes/2020/BivalentOralPolio_ArretCommercial.pdf{/aridoc}

Adresse

Address :

 à Mballa 2 près de l'hôpital Jamot de Yaoundé

Phone :

+(237) 222-21-92-81

Email:

Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

Follow us:

Changer de langue